SARS-CoV-2: Clinical Trials

2 trials for SARS-CoV-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Suspended 2

Follow SARS-CoV-2: new trials by email Literature Review of SARS-CoV-2 trials Research Report on SARS-CoV-2

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)
Hydroxychloroquine, Azithromycin, Placebo oral tablet - SARS-CoV-2, COVID-19
Phase 3SuspendedSalomeh Keyhani MD3002020-04-302020-06-22
A Trial of Remdesivir in Adults With Mild and Moderate COVID-19
Remdesivir, Remdesivir placebo - COVID-19, SARS-CoV-2
Phase 3SuspendedCapital Medical University3082020-02-122020-04-15

Narrower conditions

COVID-19 (2)

Broader conditions

Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Lung Diseases (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)

Interventions

Azithromycin (1)  ·  Hydroxychloroquine (1)  ·  remdesivir (1)

Sponsors

Capital Medical University (1)  ·  Salomeh Keyhani MD (1)

Countries

China (1)  ·  United States (1)

Top investigators

Salomeh Keyhani, MD MPH (1)

Results publications

PMID 34011199, PMID 34350582, PMID 36695483